Front-line health care workers, including Jacobs School of Medicine and Biomedical Sciences faculty and medical residents, have begun receiving their COVID-19 vaccines, with some already receiving their second dose.
The first meeting of University at Buffalo’s Cancer Research Consortium was conducted virtually Dec. 10, where it was reported that faculty are working on 97 active cancer research awards totaling $7.4 million in annual direct funding.
Thomas D. Grant, PhD, assistant professor of structural biology, is co-principal investigator on a grant from the National Science Foundation (NSF) to study how small molecules bind to the SARS-COV-2 protease to understand drug binding and help aid drug design.
Memory loss associated with Alzheimer’s disease may be able to be treated by inhibiting certain enzymes involved in abnormal gene transcription, according to a preclinical study led by senior author Zhen Yan, PhD.
At the start of the pandemic, research teams around the world began conducting studies to help further research related to vaccines for the SARS-CoV-2 coronavirus. A team led by Jonathan F. Lovell, PhD, was one of them.
Bruce R. Troen, MD, professor of medicine and chief of the Division of Geriatrics and Palliative Medicine, wants people to know that a study published this month in the Annals of Internal Medicine — which shows no benefit from higher doses of vitamin D in the frail elderly — is not the final chapter on how vitamin D affects this population.
Joseph Terrell Smith Jr., PhD, postdoctoral fellow in microbiology and immunology, has been awarded a three-year, $202,000 F32 grant from the National Institute of Allergy and Infectious Diseases to study the regulation of RNA in Trypanosoma brucei.
The Department of Orthopaedics Summer Research Program, which began in 2014 as a program for Western New York medical school students, has grown to include students from throughout the U.S.
Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a computational approach to make drug discovery faster and less expensive while also being safe and effective.
A fourth-year medical student in the Jacobs School of Medicine and Biomedical Sciences has been selected to participate in the American Medical Association (AMA) Foundation’s 2020-2021 Leadership Development Institute.
A Phase 2 research study led by Teresa Quattrin, MD, UB Distinguished Professor of pediatrics and senior associate dean for research integration, shows that the drug golimumab preserves beta-cell function in children and young adults with newly-diagnosed Type 1 diabetes for at least a year after diagnosis.
Michael W. Russell, PhD, professor emeritus of microbiology and immunology, says more COVID-19 studies should be devoted to how immunity emerges to SARS-CoV-2 in the mucous membranes of the nose and mouth.
Holiday dinner conversations sometimes erupt in heated discussions when friends and relatives with opposing political views get together. This year, whether or not to even host the dinner may be a volatile topic all by itself.
Gil I. Wolfe, MD, UB Distinguished Professor and the Irvin and Rosemary Smith Chair of neurology, served as co-chair for a panel composed of 16 international experts on myasthenia gravis (MG) who revised and expanded recommendations for managing the disease.
